Yesterday, the S&P/ASX 200 Index (ASX: XJO) jumped 1.5%.
This continued a 5-day run of volatility, as Australia's benchmark index continues to jump around significantly day to day.
In good news, there was several well-known ASX shares that rose significantly:
- Catapult Sports Ltd (ASX: CAT) shares increased 11%
- Weebit Nano Ltd (ASX: WBT) jumped 13%
- Virgin Australia Holdings Ltd (ASX: VGN) shares rose 9%
- Elevra Lithium Ltd (ASX: ELV) gained 9%
- Clarity Pharmaceuticals Ltd (ASX: CU6) rose 8%
Here's what was behind the gains, and what experts are tipping moving forward.
Image source: Getty Images
Catapult Sports
Catapult Sports shares have now gained a whopping 30% this week.
Investors are seemingly pleased with the recent FY26 results.
The results included record revenue and strong EBITDA growth.
The team at Bell Potter were impressed with results, with the broker raising its price target on these ASX shares to $4.65, and retaining its buy recommendation.
Following yesterday's closing, this updated target indicates 24% further upside.
Weebit Nano
Weebit Nano shares have exploded in 2026. The digital memory technology company has seen its share price rise almost double since the start of April.
These ASX shares are now up 300% in the last year.
This has come on the back of impressive results and capital raising efforts.
At the time of writing, Weebit Nano shares are trading for $6.79 each.
Forecasts via TradingView indicate there is still moderate upside for this technology stock.
Analysts forecast an average one year price target of $7.63, which is 12% higher than current levels.
Virgin Australia
Virgin shares rebounded 9% yesterday after a poor start to the year.
Its share price remains down 30% year to date, however it appears investors might be beginning to recognise the value in ASX travel shares.
The sector has been hit hard by surging oil prices, inflation and global conflict in 2026.
Broker forecasts currently see approximately 45% upside for Virgin shares from current levels.
Elevra Lithium
Elevra is an emerging lithium producer focused on sourcing and developing the raw materials needed to construct lithium-ion batteries, primarily lithium and graphite.
In 2026 it has benefited from surging oil costs, which has reignited the appeal for alternative energy sources.
After yesterday's 9% gain, this stock is up 400% in the last year.
Analysts forecasts indicate this rocketing lithium stock can keep climbing.
The average price target from brokers via TradingView has a one year price target of $15, indicating a further 22% upside.
Clarity Pharmaceuticals
This radiopharmaceutical company saw its shares rise 8% yesterday. Investors will be hoping this is the start of a rebound, as its share price remains down 26% year to date.
Last month, Canaccord Genuity placed a price target of $8.41 on the healthcare stock.
This price target is 200% higher than current levels.
